| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028852 |
| Receipt No. | R000033022 |
| Scientific Title | Analysis of steady state visual evoked potential, SSVEP on Irlen Syndrome |
| Date of disclosure of the study information | 2017/08/28 |
| Last modified on | 2022/03/01 (Ver. 4) |
| Basic information | ||
| Public title | Analysis of steady state visual evoked potential, SSVEP on Irlen Syndrome | |
| Acronym | SSVEP | |
| Scientific Title | Analysis of steady state visual evoked potential, SSVEP on Irlen Syndrome | |
| Scientific Title:Acronym | SSVEP | |
| Region |
|
|
| Condition | |||
| Condition | Eye disease with Irlen syndrome and photophobia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | By observing the electroencephalographic response using SSVEP on Irlen syndrome which was not abnormal in general eye examination, effectiveness of objective screening method toward Irlen syndrom's distinctive photalgia was verified. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visual acuity, intraocular pressure, fundus, OCT, visual field (Humphrey 30-2), SPP3, BUT, Schirmer test |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Visual acuity, intraocular pressure, fundus, OCT, visual field (Humphrey 30-2), SPP3, BUT, Schirmer test | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Person with Irlen syndrome
Healthy person without eye disease Person with either dry-eye, or glaucoma |
|||
| Key exclusion criteria | Person who had epilepsia
Person who got sick while watching flickering scene on the television |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Iida Municipal Hospital | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 395-8502 | ||||||
| Address | 438 Yawatamachi Iida city, Nagano | ||||||
| TEL | 0265-21-1255 | ||||||
| mori@chukyogroup.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Chukyo Eye Clinic | ||||||
| Division name | Vision Research Laboratory | ||||||
| Zip code | 456-0032 | ||||||
| Address | 12-23 Sanbonmatsu Atsuta-ku, Nagoya | ||||||
| TEL | 052-883-1543 | ||||||
| Homepage URL | |||||||
| ytanaka@chukyomedical.co.jp | |||||||
| Sponsor | |
| Institute | Chukyo Eye Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Chukyo Medical Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Chukyo Medical Co.,Ltd. REC |
| Address | 12-23 Sanbonmatsu-cho, Atsuta-ku, Nagoya-city, Aichi |
| Tel | 052-884-7976 |
| irb@chukyomedical.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 0 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033022 |